Related Experiment Video
Updated: May 20, 2026

Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting
Published on: August 4, 2023
A comparison between dexamethasone and methylprednisolone for vomiting prophylaxis after tonsillectomy in inpatient
Marie T Aouad1, Viviane G Nasr, Vanda G Yazbeck-Karam
1Department of Anesthesiology, American University of Beirut Medical Center, Beirut, Lebanon.
Insights
Methylprednisolone is as effective as dexamethasone in preventing postoperative vomiting in children after tonsillectomy. This study found methylprednisolone to be noninferior for this common surgical complication.
Area of Science:
- Pediatric Anesthesiology
- Pharmacology
Background:
- Postoperative vomiting is common in children after tonsillectomy, potentially delaying oral intake and increasing dehydration risk.
- Glucocorticoids like dexamethasone and methylprednisolone possess antiemetic properties, making them candidates for prophylactic therapy.
- Dexamethasone is frequently used, but methylprednisolone's efficacy in this context requires evaluation.
Purpose of the Study:
- To determine if methylprednisolone is noninferior to dexamethasone in preventing postoperative vomiting in children undergoing tonsillectomy.
- To compare the antiemetic efficacy of a single prophylactic dose of methylprednisolone versus dexamethasone.
Main Methods:
- A randomized double-blind trial involving 160 children undergoing tonsillectomy.
- Comparison of a single prophylactic dose of IV methylprednisolone (2.5 mg/kg) versus IV dexamethasone (0.5 mg/kg) after anesthesia induction.
- Primary outcome: incidence of postoperative vomiting within 24 hours, with a noninferiority margin of 9%.
Main Results:
- Intention-to-treat analysis showed a vomiting incidence of 22% for methylprednisolone versus 30% for dexamethasone (difference 8%).
- Per protocol analysis revealed vomiting incidence of 23% for methylprednisolone and 32% for dexamethasone (difference 9%).
- Oral intake, hydration duration, pain, and satisfaction scores were similar between groups.
Conclusions:
- Methylprednisolone demonstrated noninferiority to dexamethasone in preventing vomiting after tonsillectomy in children.
- The study supports methylprednisolone as a viable alternative for managing postoperative nausea and vomiting in this pediatric population.
Background:
The frequent incidence of postoperative vomiting in children undergoing tonsillectomy, in addition to the occurrence of severe pain, may delay postoperative oral intake and lead to increased risk of dehydration. Thus, prophylactic therapy is indicated in this high-risk group. Glucocorticoids, such as dexamethasone and methylprednisolone, have anti-inflammatory and antiemetic properties with dexamethasone being frequently used. We hypothesized that methylprednisolone should be noninferior to dexamethasone for the prevention of vomiting in children after tonsillectomy.
Methods:
We designed a randomized double-blind trial to compare the efficacy of a single prophylactic dose of 0.5 mg/kg dexamethasone with a dose of 2.5 mg/kg methylprednisolone on the incidence of postoperative vomiting during the first 24 hours (primary outcome) in children undergoing total or partial tonsillectomy with a noninferiority margin set at 9%. One hundred sixty children undergoing total or partial tonsillectomy under general anesthesia were randomly assigned to receive either IV dexamethasone 0.5 mg/kg (n = 79) or methylprednisolone 2.5 mg/kg (n = 81) after induction of anesthesia. Secondary analysis of all studied outcomes was also performed according to the type of surgery.
Results:
An intention-to-treat analysis showed an overall incidence of vomiting of 30% in the dexamethasone group and of 22% in the methylprednisolone group (difference: 8%, 95% confidence interval [CI]: -5% to 21%). A per protocol analysis showed an incidence of vomiting of 32% and 23%, respectively (difference: 9%, and 95% CI of the difference: -5 to 23%, P(sup) = 0.28). The time and quality of oral intake and the duration of IV hydration, as well as pain and satisfaction scores and the need for analgesics, were similar between the 2 groups. The incidence of vomiting was also similar in patients who had total versus partial tonsillectomy; however, time to first oral intake, duration of IV hydration, and the need for analgesics were less with better satisfaction scores in partial versus total tonsillectomy patients.
Conclusion:
Methylprednisolone is at worst 5% less effective than dexamethasone by the intention-to-treat analysis, and by the per protocol analysis. Thus, it is noninferior to dexamethasone in preventing vomiting after tonsillectomy in children.
Related Concept Videos
Tonsillitis II: Management
Drug Dosing: Infants and Children
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Parenteral Anesthetics: Overview